title: Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.
abstract: Capecitabine is an oral prodrug of 5-fluorouracil and is commonly used oral chemotherapeutic drugs for advanced gastric and colorectal cancer. However, hand-foot syndrome (HFS) has high incidence, and once developed, the symptoms significantly impair quality of life (QOL), leading to a reduction in the dosage or discontinuation of the treatment. Effective health education should be offered to patients to promote self-identification and management on how to recognize HFS and use self-management techniques at the very beginning of chemotherapy.
  
  
  
  The present study intended to evaluate the effectiveness of structured teaching program on knowledge related to self-identification and management of HFS among patients receiving chemotherapy for colon cancer at tertiary cancer care center. Participants who fulfilled the criteria were selected using non-probability purposive sampling. The sample selected were 40 participants (20 participants in experimental group and 20 participants in control group).
  
  
  
  Among the group of 40 patients, 17 (85 %) participants in the experimental group and 17 (85 %) participants in the control group were receiving capecitabine and oxaliplatin (CAPOX) chemotherapy treatment protocol. Five (25 %) participants in the experimental group and ten (50 %) participants in the control group were receiving drug capecitabine at a dose of 2500 mg. The mean knowledge (knowledge related to self-identification and management of HFS) pretest score was 6.75 and mean knowledge posttest score was 10.25 in the experimental group which was statistically significant (p = 0.000) (p < 0.05). The mean knowledge pretest score of participants was 6.45 and mean knowledge posttest score of participants was 6.75 in the control group which was not statistically significant (p = 0.67) (p > 0.05).
  
  
  
  The study showed a statistically significant improvement in knowledge scores of participants that occurred due to intervention of structured teaching program. This can be used to assess reduction in incidence of HFS in the future.
authors.affiliation: Department of Nursing, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Kalaivani
authors.initials: K
authors.lastname: Murugan
authors.affiliation: Department of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, India. dr.vikas.ostwal@gmail.com.|Medical Oncology, Tata Memorial Centre, Office 323, HBB, Parel, Mumbai, 400012, India. dr.vikas.ostwal@gmail.com.
authors.forename: Vikas
authors.initials: V
authors.lastname: Ostwal
authors.affiliation: Department of Nursing, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Maria Deo
authors.initials: MD
authors.lastname: Carvalho
authors.affiliation: Department of Nursing, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Anita
authors.initials: A
authors.lastname: D'souza
authors.affiliation: Department of Nursing, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Meera S
authors.initials: MS
authors.lastname: Achrekar
authors.affiliation: Department of Nursing, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Shrinivasan
authors.initials: S
authors.lastname: Govindarajan
authors.affiliation: Department of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Sudeep
authors.initials: S
authors.lastname: Gupta
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D000069287:Capecitabine / Q000008:administration & dosage / Q000009:adverse effects; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects; D019468:Disease Management; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D060831:Hand-Foot Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D000077150:Oxaliplatin; D010353:Patient Education as Topic / Q000379:methods*; D011788:Quality of Life; D012648:Self Care; D055815:Young Adult
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil
keywords: Capecitabine; HFS; Knowledge; Structured teaching module